Medidata Solutions (NASDAQ:MDSO) is scheduled to be releasing its earnings data before the market opens on Tuesday, April 24th. Analysts expect Medidata Solutions to post earnings of $0.34 per share for the quarter.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings results on Thursday, February 8th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.31 by $0.10. The business had revenue of $141.20 million during the quarter, compared to the consensus estimate of $140.65 million. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The business’s revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.33 EPS. On average, analysts expect Medidata Solutions to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Shares of NASDAQ MDSO opened at $67.46 on Tuesday. The company has a market cap of $3,935.46, a PE ratio of 79.36, a PEG ratio of 3.49 and a beta of 1.53. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.49 and a quick ratio of 1.49. Medidata Solutions has a 1 year low of $59.22 and a 1 year high of $85.92.
In other Medidata Solutions news, CEO Tarek Sherif sold 26,836 shares of the firm’s stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $70.25, for a total value of $1,885,229.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Rouven Bergmann sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $66.46, for a total transaction of $132,920.00. Following the completion of the transaction, the chief financial officer now directly owns 87,775 shares of the company’s stock, valued at approximately $5,833,526.50. The disclosure for this sale can be found here. Insiders sold a total of 35,836 shares of company stock valued at $2,495,689 in the last three months. 5.80% of the stock is currently owned by corporate insiders.
Several research firms recently weighed in on MDSO. TheStreet upgraded shares of Medidata Solutions from a “c+” rating to a “b-” rating in a report on Monday, March 12th. BidaskClub upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. ValuEngine downgraded shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Saturday, March 17th. Zacks Investment Research downgraded shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Thursday, April 12th. Finally, Needham & Company LLC dropped their target price on shares of Medidata Solutions to $75.00 and set a “buy” rating for the company in a report on Friday, February 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $82.07.
TRADEMARK VIOLATION WARNING: “Medidata Solutions (MDSO) Set to Announce Earnings on Tuesday” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/04/17/medidata-solutions-mdso-set-to-announce-earnings-on-tuesday.html.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.